| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/22/2006 | EP1635828A1 4-(2-phenyloxyphenyl)-piperidine or -1,2,3,6-tetrahydropyridine derivatives as serotonin reuptake inhibitors |
| 03/22/2006 | EP1368345B1 Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 03/22/2006 | EP1322635B1 Farnesyl transferase inhibiting quinoline and quinazoline derivatives as farnesyl transferase inhibitors |
| 03/22/2006 | EP1309586B1 4-, 5-, 6- and 7-indole derivatives useful for the treatment of cns disorders |
| 03/22/2006 | EP1140924B1 Piperazine derivatives |
| 03/22/2006 | EP0962456B1 Cyclic ketone derivative and pharmaceutical use thereof |
| 03/22/2006 | CN1751040A Benzofuran oxyethylamines serving as antidepressant drugs and anxiolytic drugs |
| 03/22/2006 | CN1751039A Pyridine derivatives as fungicidal compounds |
| 03/22/2006 | CN1751033A Bicyclic heterocycles, medicaments containing said compounds, use thereof, and method for the production thereof |
| 03/22/2006 | CN1751023A Piperidine-benzenesulfonamide derivatives |
| 03/22/2006 | CN1750823A Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 03/22/2006 | CN1246319C Amino (thio) ether derivative |
| 03/22/2006 | CN1246315C Amino alkoxybenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same |
| 03/21/2006 | US7015328 Substituted coumarins and quinolines and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/21/2006 | US7015320 Process for the manufacture of optically active 3-substituted lactams by asymmetric hydrogenation of 3-alkylidenelactams |
| 03/21/2006 | US7015241 Appetite-stimulating agents and remedies for anorexia |
| 03/21/2006 | US7015237 Pyridine matrix metalloproteinase inhibitors |
| 03/21/2006 | US7015234 Hydroxamic acid derivatives |
| 03/21/2006 | US7015220 enzyme inhibitors used as modulators of tyrosine kinase signal transduction and/or as antiproliferative agents; prophylaxis of vision defects, cancer, atherosclerosis, restenosis, metabolic disorders or autoimmune diseases |
| 03/21/2006 | US7015218 Amide compounds and medicinal use thereof |
| 03/21/2006 | US7015214 Such as 7-chloro-2-cyanoimino-5-(cyclopropylmethyloxy)-1,5-dihydro-5-trifluoromethyl-1,3-benzodiazepine |
| 03/21/2006 | US7014796 Irradiation with microwaves |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/21/2006 | CA2238816C N-acyl-2-substituted-4-(benzimidazolyl- or imidazopyridinyl-substituted residues)-piperidines as tachykinin antagonists |
| 03/21/2006 | CA2124932C Sex steroid activity inhibitors |
| 03/16/2006 | WO2006029154A2 Novel compounds |
| 03/16/2006 | WO2006028958A2 Pyridyl inhibitors of hedgehog signalling |
| 03/16/2006 | WO2006028957A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | WO2006028904A1 Quinazolines useful as modulators of ion channels |
| 03/16/2006 | WO2006028239A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | WO2006027628A2 Naphthalimide derivatives as antiviral agents |
| 03/16/2006 | WO2006027211A1 2,4-substituted pyrimidines as cysteine protease inhibitors |
| 03/16/2006 | WO2006027186A1 N-(1-(2,3-dihydro-1h-inden-5yl) -2-oxo-3-pyrrolidinyl) -sulfonamide derivatives for use as factor xa inhibitors |
| 03/16/2006 | WO2005121121A3 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto |
| 03/16/2006 | WO2005113535A3 Pyrazinylmethyl lactam derivatives |
| 03/16/2006 | WO2005113494A3 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer |
| 03/16/2006 | WO2005100349A3 Polycyclic pyridines as potassium ion channel modulators |
| 03/16/2006 | WO2005077344A3 Hydantoin derivatives as inhibitors of cellular necrosis |
| 03/16/2006 | US20060058553 Novel bicyclic hydroxamates as inhibitors of histone deacetylase |
| 03/16/2006 | US20060058533 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms |
| 03/16/2006 | US20060058527 suitable as synthones for the construction of complex molecules containing tetrahydropyran units; pent-1-al and methyl acrylate as starting material for preperation of tetrahydrofurans |
| 03/16/2006 | US20060058372 N-Benzodioxolyl, n-benzodioxanyl and n-benzodioxepinyl arylcarboxamide derivatives and pharmaceutical compositions comprising them |
| 03/16/2006 | US20060058368 Such as (1-Benzyl-2-hydroxy-3-{isobutyl-[2-oxo-3-(1H-pyrrol-2-ylmethylene)-2,3-dihydro-1H-indole-5-sulfonyl]-amino}-propyl)-carbamic acid hexahydro-furo[2,3-b]furan-3-yl ester; multi-drug resistant HIV infections |
| 03/16/2006 | US20060058353 Benzofuran derivatives, process for their preparation and intermediates thereof |
| 03/16/2006 | US20060058349 Piperidinetriol derivatives as inhibitors of glycosyceramid synthase |
| 03/16/2006 | US20060058329 Pyrazole inhibitors of the transforming growth factor |
| 03/16/2006 | US20060058302 Antiinflammatory agents; osteoporosis; rheumatic diseases; autoimmune diseases; example compound: 2-Chloro-5-(3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl)-N-(2-ethyl-hexyl)-benzamide |
| 03/16/2006 | US20060058292 2,4-pyrimidinediamine compounds and their uses |
| 03/16/2006 | US20060058285 Substituted 4-(4-piperidin-4-yl-piperazin-1-yl)-azepane derivatives and their use as neurokinin antagonists |
| 03/16/2006 | CA2579204A1 Carbamoyl-substituted spiro derivative |
| 03/16/2006 | CA2578996A1 4-substituted 4, 6-dialkoxy-cinnoline derivatives as phospodiesterase 10 inhibitors for the treatment of psychiatric or neurological syndroms |
| 03/16/2006 | CA2578739A1 Quinazolines useful as modulators of ion channels |
| 03/15/2006 | EP1634876A2 Heterocyclic compounds for the treatment of hyperlipidemia agents |
| 03/15/2006 | EP1634606A1 Drug for airway administration |
| 03/15/2006 | EP1633743A1 Cyclic amine derivatives and their use in the treatment of inflammation-related disorders mediated by bradykinin |
| 03/15/2006 | EP1633742A1 Indole derivative in the form of serotonin reabsorbing inhibitors |
| 03/15/2006 | EP1633741A1 Indole derivatives as serotonin reuptake inhibitors |
| 03/15/2006 | EP1633740A2 Chemical compounds |
| 03/15/2006 | EP1633738A2 Novel indole derivatives, method of preparing same in the form of medicaments, pharmaceutical compositions and, in particular, kdr inhibitors |
| 03/15/2006 | EP1633734A2 Mucin synthesis inhibitors |
| 03/15/2006 | EP1633733A1 Cannabinoid derivatives, methods of making, and use thereof |
| 03/15/2006 | EP1633732A1 Benzyl sulfonamide derivatives as androgen receptor antagonists |
| 03/15/2006 | EP1633726A1 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2 |
| 03/15/2006 | EP1633725A1 Hepatitis c virus inhibitors |
| 03/15/2006 | EP1633724A1 Phthalazinone derivatives |
| 03/15/2006 | EP1633722A2 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity |
| 03/15/2006 | EP1633710A1 Isoindolin-1-one compounds as kinase inhibitors |
| 03/15/2006 | EP1633709A1 Anti-diabetic agents |
| 03/15/2006 | EP1608634A4 Methods for isolating crystalline form i of 5-azacytidine |
| 03/15/2006 | EP1567151B1 3-(2-hydroxy-phenyl)-1h-pyrazole-4-carboxylic acid amide derivatives as hsp90 inhibitors for the treatment of cancer |
| 03/15/2006 | EP1448566B1 Chemokine receptor antagonists and methods of use thereof |
| 03/15/2006 | CN1747952A Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis |
| 03/15/2006 | CN1747950A 2-(1h-indazole-6-ylamino)-benzamide compounds as protein kinases inhibitors useful for the treatment of ophthalmic diseases |
| 03/15/2006 | CN1747936A Substituted azole derivatives as therapeutic agents |
| 03/15/2006 | CN1747929A Inhibitors of the binding of chemokines i-tac or sdf-1 to the ccxckr2 receptor |
| 03/15/2006 | CN1747732A 2-aminocarbonyl-quinoline compounds as platelet adenosine diphosphate receptor antagonists |
| 03/15/2006 | CN1747730A Pyrazole derivatives modulators of hepatocyte growth factor (scatter factor) activity |
| 03/15/2006 | CN1746168A Optically active doxazosin |
| 03/15/2006 | CN1245401C 6-aryl-4-aminopicolinates and their use as herbicides |
| 03/15/2006 | CN1245386C 1,2-dihydropyridine compounds, process for preparation of same and use thereof |
| 03/15/2006 | CN1245384C Carboxamides as fungicides in agriculture |
| 03/15/2006 | CN1245380C Anthranilic acid derivatives |
| 03/14/2006 | US7012094 such as 3-(4-fluorophenyl)-4-(methylsulfonylphenyl)furan; for treatment of arthritis |
| 03/14/2006 | US7012088 Indolone oxazolidinones and derivatives thereof |
| 03/14/2006 | US7012085 As antipsychotics in therapy of schizophrenia, depression, bipolar disorders, cognition deficits, Parkinson disease, drug abuse, attention deficit hyperactivity disorders, glaucoma, diabetes and erectile dysfunction |
| 03/14/2006 | US7012083 For prophylaxis and therapy of pruritus |
| 03/14/2006 | US7012081 Antiproliferative agents; skin disorders; vision defects; liver and kidney disorders |
| 03/14/2006 | US7012078 For therapy and prophylaxis of migraine, inflammatory diseases, stroke, acute and chronic pain, hypovolemic shock, traumatic shock, reperfusion injury, Crohn's disease, ulcerative colitis, septic shock, multiple sclerosis, etc. |
| 03/14/2006 | US7012073 Quinoline derivatives |
| 03/14/2006 | CA2359363C 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists |
| 03/14/2006 | CA2312935C Hydroxamic acid derivatives as matrix metalloprotease (mmp) inhibitors |
| 03/14/2006 | CA2297825C Indole and 2,3-dihydroindole derivatives, their preparation and use |
| 03/14/2006 | CA2278241C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 03/14/2006 | CA2267879C Heteroaryl succinamides and their use as metalloproteinase inhibitors |
| 03/14/2006 | CA2165800C Antiallergic imidazoazepines |
| 03/14/2006 | CA2051494C 1-aryl-3-pyridinyl-2-propene-1-ones as calcium uptake inhibitors |
| 03/09/2006 | WO2006025979A2 Modulators of nuclear receptors |
| 03/09/2006 | WO2006025471A1 Piperidine derivative or pharmaceutically acceptable salt thereof |
| 03/09/2006 | WO2006024837A1 Isoindolin-1-one derivatives |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |